Strategy Analysis

Opinion: I led the CDC response to the 2014 Ebola epidemic. The new outbreak needs massive

CDC · Ebola · 5 min

Amish Health Beliefs: Vaccines, Costs, and Pharma Strategy Insights

5 min

OHRP Underfunding Risks Human Subject Protection in 2026

5 min

STAT+: RFK Jr.’s second year: Vacancies, not vaccines

NIH · 4 min

HHS Confirms Americans with High-Risk Ebola Exposures Will Have Access to Experimental Therapy MBP-134

HHS · Ebola · 4 min

AI Titans Push Congress for DNA Safeguards: Implications for Biotech Strategy

4 min

Pharma Pulse: 340B Uncertainty, Drug Shortages, and Wegovy's Global Debut

FDA · 8 min

ASCO26: Gastrointestinal Cancers Enter the Limelight Amid Key Readout Surge

oncology · 4 min

Genstar-backed Signant Health Acquires Ametris: Implications for eCOA and Digital Outcome Measures

6 min

FDA Concerns About Cancer Risk Sink Fulcrum Therapeutics’ Sickle Cell Disease Drug: Implications for SCD Pipeline and BD Strategy

FDA · sickle cell disease · 4 min

Kailera's Triple-G Drug: A Potential Game-Changer in Pharma

FDA · 5 min

FDA's Future: Insights from Former Commissioner David Kessler

FDA · 5 min